About Amryt Pharma PLC
Amryt Pharma plc, formerly Fastnet Equity plc, is a United Kingdom-based specialty pharmaceutical company. The Company focuses on developing and delivering treatments for patients with rare and orphan diseases. The Company's products include Episalvan and Imlan. The Company's products focus on developing somatostatin analogue (SSA) peptide medicines for patients with rare neuroendocrine diseases, including acromegaly and Cushing's disease. The Company's Episalvan is a prescription pharmaceutical product, which accelerates wound healing. The Company's Episalvan consists of two ingredients, such as betulin-based active ingredient and sunflower oil as the excipient. The Company's Imlan products have regenerative and anti-inflammatory properties. Betulin is the active ingredient in the Imlan products and functions as the stabilizer of the creams and lotions. The Company's Imlan Creme Pur consists of Betulin, oil and water ingredients.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: LON
- Symbol: FAST
- Previous Close: $0.04
- 50 Day Moving Average: $2.91
- 200 Day Moving Average: $2.54
- 52-Week Range: GBX 1.85 - GBX 3.90
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Market Cap: $N/A
Consensus Ratings for Amryt Pharma PLC (LON:FAST) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||1 Hold Rating|
|Consensus Rating:||Hold (Score: 2.00)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Amryt Pharma PLC (LON:FAST)
(Data available from 2/24/2015 forward)
|2/7/2017||Beaufort Securities||Reiterated Rating||Speculative Buy|
|3/26/2015||Davy Research||Reiterated Rating||Outperform|
Earnings History for Amryt Pharma PLC (LON:FAST)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Amryt Pharma PLC (LON:FAST)
Current Year EPS Consensus Estimate: $-0.33 EPS
Dividend History for Amryt Pharma PLC (LON:FAST)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Amryt Pharma PLC (LON:FAST)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
Latest Headlines for Amryt Pharma PLC (LON:FAST)
What is Amryt Pharma PLC's stock symbol?
Amryt Pharma PLC trades on the London Stock Exchange (LON) under the ticker symbol "FAST."
How do I buy Amryt Pharma PLC stock?
Shares of Amryt Pharma PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Amryt Pharma PLC stock cost?
One share of Amryt Pharma PLC stock can currently be purchased for approximately GBX 2.97.